Fischell Tim A, Malhotra Surender, Khan Shakeel
Ostial Solutions, LLC.
Catheter Cardiovasc Interv. 2008 Feb 15;71(3):353-7. doi: 10.1002/ccd.21391.
The stenting of aorto-ostial lesions in the native coronary circulation, renal arteries, and saphenous vein grafts is technically challenging.
We report the first in the world use of the Ostial Protrade mark, a novel nitinol-based device, utilized in conjunction with standard stenting techniques to assist in the precise placement of stents for the treatment of aorto-ostial lesions.
The Ostial Pro, is a relatively simple nitinol device that is positioned within the guiding catheter. It has distal, self-expanding legs that are advanced just distal to the tip of the guiding catheter after the ostial lesion has been crossed with the coronary guidewire and stent delivery system. The expanded nitinol legs prevent the entry of the guiding catheter into the target vessel, mark the plane of the aortic wall, and align the tip of the guide with the aorto-ostial plane. We report the successful and precise placement of stents in the aorto-ostial location in two patients with; (1) a saphenous vein graft ostial lesion and (2) a right coronary ostial lesion, using the new Ostial Pro stent positioning device. Excellent stent positioning, relative to the aorto-ostial plane, was confirmed by angiography and long axis intravascular ultrasound in both cases.
(1) The Ostial Pro is a new, commercially available (FDA cleared), nitinol device that is simple to use and appears effective in allowing the precise placement of stent(s) at the aorto-ostial location. (2) This approach may provide a simple and effective means to assure accurate stent placement in these difficult to treat lesions.
在自身冠状动脉循环、肾动脉和大隐静脉移植血管中对主动脉开口病变进行支架置入术在技术上具有挑战性。
我们报告了世界上首次使用Ostial Pro商标的新型镍钛诺装置,该装置与标准支架置入技术联合使用,以协助精确放置支架来治疗主动脉开口病变。
Ostial Pro是一种相对简单的镍钛诺装置,放置在引导导管内。在冠状动脉导丝和支架输送系统穿过开口病变后,其远端的自膨胀支腿会推进到引导导管尖端的远侧。膨胀后的镍钛诺支腿可防止引导导管进入目标血管,标记主动脉壁平面,并使引导导管尖端与主动脉开口平面对齐。我们报告了使用新型Ostial Pro支架定位装置在两名患者的主动脉开口部位成功且精确地放置了支架;(1)一名患者患有大隐静脉移植血管开口病变,(2)另一名患者患有右冠状动脉开口病变。在这两例病例中,通过血管造影和长轴血管内超声均证实相对于主动脉开口平面支架定位良好。
(1)Ostial Pro是一种新的、已获美国食品药品监督管理局批准上市的镍钛诺装置,使用简单,在使支架精确放置于主动脉开口部位方面似乎有效。(2)这种方法可能提供一种简单有效的手段,以确保在这些难以治疗的病变中准确放置支架。